Improve Communication
The CEBRE guides use graphic narrative to help patients better
With Your Patients
understand the treatment process. The entire series can be
downloaded for free by all practices.
Elevate Your Practice with the
ROI has compiled all the best radiation oncology resources
RadOnc Toolbox
in a single app including staging, guidelines, contouring,
dose constraints, calculators and more!
Your gift will help
accelerate bold and innovative
ideas in radiation therapy
Every day, more than 5,000 Americans are diagnosed with cancer.
Every person, during every step of their journey, deserves the best treatment possible.
Radiation therapy is a safe and effective cancer treatment, and it has been for more than 100 years. Yet, radiation therapy research is limited.
Established in 2006, the Radiation Oncology Institute (ROI) – The ASTRO Foundation – is a 501(c)(3) public charity committed to accelerating bold and innovative ideas in radiation therapy so that every person has access to the best radiation therapy to life a longer, healthier life.
We have funded more than $4.7 million in research and education so far. And with your help, we will continue to deliver vital resources to passionate investigators so they can create tools and discover solutions to support health care professionals who provide care for people living with cancer.
ROI is accepting nominations of outstanding early career investigators for the 2025 Publication Excellence Awards. Authors who have recently published results of exceptional research in radiation oncology that addresses one or more of the ROI priorities are eligible to win $1,500 and be recognized at this year's ASTRO Annual Meeting. Nominations are due by July 7 at 5:00 p.m. Eastern.
Stay connected by following us on our social media pages:
When you support ROI, you are driving research to increase the understanding and awareness of radiation therapy, helping to uncover treatment and cures and advancing radiation treatment that will improve quality of life and outcomes for patients with cancer.
